Volume 28, Number 4—April 2022
Synopsis
Increasing Antimicrobial Resistance in World Health Organization Eastern Mediterranean Region, 2017–2019
Maha Talaat
, Bassem Zayed, Sara Tolba, Enjy Abdou, Mohamed Gomaa, Dana Itani, Yvan Hutin, and Rana Hajjeh
, Bassem Zayed, Sara Tolba, Enjy Abdou, Mohamed Gomaa, Dana Itani, Yvan Hutin, and Rana Hajjeh
Table 2
Implementation status of select core elements of national AMS programs in 20 countries in the World Health Organization Eastern Mediterranean Region, 2020*
| Activities | Countries, no. (%) |
|---|---|
| National core elements, national plans, and strategies | |
| Dedicated funding for AMR and AMS activities | 1/20 (5) |
| Establishment of AMS technical working group with defined terms of references | 4/20 (20) |
| Development of AMS implementation plan with short-, medium-, and long-term goals |
1/20 (5) |
| Regulations and guidelines | |
| Presence of national Essential Medicines List | 13/20 (65) |
| National EML adopts AWaRe classification | 2/13 (15.5) |
| Development of updated treatment guidelines for common infections | 5/20 (25) |
| Existing treatment guidelines integrate the AWaRe classification | 1/5 (20) |
| Presence of prescription only sale policy for antimicrobial drugs | 10/20 (50) |
| Enforcement of prescription only sale policy for antimicrobial drugs |
5/10 (50) |
| Awareness, training, and education | |
| In-service training for AMS teams on AMS and antimicrobial drug prescribing | 0/20 |
| In-service training for healthcare professionals on AMS and antimicrobial drug prescribing | 2/20 (10) |
| AMS criteria for hospitals accreditation, set by ministry of health | 4/20 (20) |
*AMR, antimicrobial resistance; AMS, antimicrobial stewardship; AWaRe, Access, Watch, or Reserve.
Page created: January 10, 2022
Page updated: March 19, 2022
Page reviewed: March 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.